synergistic mixtures of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy) quinazoline, fluorouracil or irinocetan, for the treatment of cancers; angiogenesis inhibitors and vascular permeability reducing effect in mammals
2004
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI